BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 23273978)

  • 1. eRNAs are required for p53-dependent enhancer activity and gene transcription.
    Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
    Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
    Polson A; Takahashi P; Reisman D
    Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
    Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
    Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
    Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response.
    Melo CA; Léveillé N; Rooijers K; Wijchers PJ; Geeven G; Tal A; Melo SA; de Laat W; Agami R
    Oncogene; 2016 Aug; 35(33):4399-406. PubMed ID: 26776159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
    Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
    Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eRNA binding produces tailored CBP activity profiles to regulate gene expression.
    Bose DA; Berger SL
    RNA Biol; 2017 Dec; 14(12):1655-1659. PubMed ID: 28891741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
    Millau JF; Bastien N; Bouchard EF; Drouin R
    Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis.
    Schavolt KL; Pietenpol JA
    Oncogene; 2007 Sep; 26(42):6125-32. PubMed ID: 17404570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
    Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
    Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitofusin-2 is a novel direct target of p53.
    Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
    Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.